| 1 |
34407453 | Pharmacologic and genetic inhibition of cholesterol esterification enzymes reduces tumour burden: A systematic review and meta-analysis of preclinical models. | 2022 Feb |
1 |
| 2 |
34914638 | Ceramide-mediated gut dysbiosis enhances cholesterol esterification and promotes colorectal tumorigenesis in mice. | 2022 Feb 8 |
1 |
| 3 |
32451414 | Avasimibe exerts anticancer effects on human glioblastoma cells via inducing cell apoptosis and cell cycle arrest. | 2021 Jan |
1 |
| 4 |
33637695 | Cholesterol activates the Wnt/PCP-YAP signaling in SOAT1-targeted treatment of colon cancer. | 2021 Feb 26 |
1 |
| 5 |
34052835 | Simultaneously targeting SOAT1 and CPT1A ameliorates hepatocellular carcinoma by disrupting lipid homeostasis. | 2021 May 29 |
1 |
| 6 |
34790132 | SOAT1 Promotes Gastric Cancer Lymph Node Metastasis Through Lipid Synthesis. | 2021 |
1 |
| 7 |
26982734 | Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. | 2016 Mar 31 |
1 |
| 8 |
19167888 | Novel 1,4-diarylpiperidine-4-methylureas as anti-hyperlipidemic agents: dual effectors on acyl-CoA:cholesterol O-acyltransferase and low-density lipoprotein receptor expression. | 2009 Feb 15 |
1 |
| 9 |
12595916 | Pharmacology of the ACAT inhibitor avasimibe (CI-1011). | 2003 Spring |
3 |
| 10 |
11882316 | Anti-atherogenic effects of the acyl-CoA:cholesterol acyltransferase inhibitor, avasimibe (CI-1011), in cultured primary human macrophages. | 2002 Mar |
2 |
| 11 |
12498009 | Avasimibe Pfizer. | 2002 Sep |
3 |
| 12 |
10195921 | ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB. | 1999 Apr |
4 |
| 13 |
9568739 | The ACAT inhibitor, CI-1011 is effective in the prevention and regression of aortic fatty streak area in hamsters. | 1998 Mar |
1 |